Figure 5From: XVII International AIDS Conference: From Evidence to Action - Clinical and biomedical prevention scienceVirological suppression sratified by baseline CD4+ counts (>/< 50 cell/mm3). Source: Madero, S. et al. A prospective, randomized, open label trial of efavirenz versus lopinavir/ritonavir based HAART among antiretroviral therapy naïve, HIV infected individuals presenting for care with CD4 cell counts. (TUAB0104)Back to article page